Overview
Announcement
We are pleased to announce that Cellular Oncology will become a fully open access (OA) on 1 January 2025. As a result, all submissions received from 3rd September 2024 are subject to an article publication charge (APC) if accepted and published in the journal (unless a waiver is applied). Please see our FAQs which can be found at the bottom of this page for more information on APCs, funding options, waivers and the journal's transition to fully open access.
Cellular Oncology publishes cutting-edge research from various biomedical and clinical disciplines involved in basic and translational cancer research on the cell and tissue level.
- Provides a platform for molecular biologists and geneticists, technical developers, pathologists, (medical) oncologists, and other clinicians involved in managing cancer patients.
- Addresses the conversion of cell biology to clinical applications
- Co-Editor-in-Chief
-
- Cun Wang,
- Xiaohang Qiao
- Journal Impact Factor
- 4.9 (2023)
- 5-year Journal Impact Factor
- 5.2 (2023)
- Submission to first decision (median)
- 4 days
- Downloads
- 396,280 (2023)
Latest articles
Journal updates
-
Cellular Oncology is transitioning to full open access!
We are excited to announce that Cellular Oncology will become a fully open access (OA) journal in 2025. This means that as of January 2025, we will only be publishing open access articles, meaning content will be freely available to readers worldwide, enabling the widest possible dissemination and reuse.
-
Transition to fully OA FAQ
Frequently asked questions regarding the transition to fully open access and what this means for the Cellular Oncology.
-
New Article Type
The Editors-in-Chief would like to annouce a brand new article type called Research Highlights. They have also updated the critera for Brief Reports. Please read on for more details.
-
Trending articles from the past 12 months
Find out which Cellular Oncology articles are attracting the most attention on the social web.
Journal information
- Electronic ISSN
- 2211-3436
- Print ISSN
- 2211-3428
- Abstracted and indexed in
-
- BFI List
- BIOSIS
- Baidu
- Biological Abstracts
- CAB Abstracts
- CLOCKSS
- CNKI
- CNPIEC
- Chemical Abstracts Service (CAS)
- Current Contents/Clinical Medicine
- Current Contents/Life Sciences
- Dimensions
- EBSCO
- EMBASE
- Google Scholar
- Japanese Science and Technology Agency (JST)
- Medline
- Meta
- Naver
- OCLC WorldCat Discovery Service
- Portico
- ProQuest
- Reaxys
- SCImago
- SCOPUS
- Science Citation Index Expanded (SCIE)
- TD Net Discovery Service
- UGC-CARE List (India)
- Wanfang
- Copyright information